Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts
- 1 March 1999
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (3) , 512-520
- https://doi.org/10.1016/s0959-8049(98)00416-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloidBiochemical Pharmacology, 1998
- Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloidCancer Chemotherapy and Pharmacology, 1998
- Vinca Alkaloids in Superacidic Media: A Method for Creating a New Family of Antitumor DerivativesJournal of the American Chemical Society, 1997
- Human Tumor Xenograft Models in NCI Drug DevelopmentPublished by Springer Nature ,1997
- Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in miceAnti-Cancer Drugs, 1996
- Vinorelbine: an overviewCancer Treatment Reviews, 1996
- DNA‐repeat instability is associated with colorectal cancers presenting minimal chromosome rearrangementsGenes, Chromosomes and Cancer, 1995
- Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenograftsEuropean Journal Of Cancer, 1992
- Establishment and characterization of five cell lines derived from human malignant gliomasActa Neuropathologica, 1987
- New Human Tumor Cell LinesPublished by Springer Nature ,1975